After pressure, Biogen to expand compassionate use for ALS drug
Following pressure by advocates for patients with amyotrophic lateral sclerosis, or ALS, Biogen has expanded its early access program to an experimental ALS drug called tofersen.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Rowan Walrath Source Type: news